Researchers are making important progress in understanding the hidden brain changes linked to suicide risk.
A new study suggests that a medication already used for mood disorders may help reduce dangerous impulsive thinking in people who have survived severe suicide attempts.
The study, carried out by scientists from Texas A&M University and Baylor College of Medicine, examined how lithium affects brain activity related to impulse control and decision-making. The findings were published in the journal Experimental and Clinical Psychopharmacology.
Suicide is a major global health crisis. Health experts estimate that hundreds of thousands of people die from suicide each year, and many more struggle with suicidal thoughts or survive suicide attempts. One of the biggest challenges for doctors is identifying who may be at risk before another crisis happens.
Researchers have long known that impulsive behavior can increase suicide risk. During periods of extreme emotional pain, some people may act quickly without fully thinking through the consequences. Scientists believe the brain systems involved in impulse control may work differently in people at high risk for suicide.
To explore this idea, the research team studied people who had survived medically severe suicide attempts. These participants were recruited from emergency and veterans medical centers in Texas.
The scientists used electroencephalography, also called EEG, to monitor brain activity. EEG records electrical signals produced by the brain using small sensors attached to the scalp. The test is painless and widely used to study brain function.
Researchers compared participants with severe suicide attempt histories to similar psychiatric patients without such histories. They found that the high-risk participants showed greater impulsivity and higher levels of emotional arousal before treatment began.
The study then tested whether lithium could improve these brain patterns.
Lithium is one of the oldest medications used in psychiatry. It has been prescribed for decades to help stabilize mood in people with bipolar disorder. Doctors have also noticed for many years that lithium treatment appears linked to lower suicide rates, but the biological reason behind this effect has remained unclear.
In this study, participants received either lithium or placebo pills during different parts of the trial. Because the study was double-blind and randomized, neither participants nor researchers knew who was receiving lithium at a given time.
After lithium treatment, researchers observed improvements in decision-making and impulse control. EEG scans also showed changes in brain signals connected to self-control and slower reactions.
According to Dr. Nicholas Murphy, one of the lead researchers, lithium appeared to give people more time to think before acting. This slowing of impulsive decisions may be especially important during suicidal crises, when actions can happen very quickly under emotional stress.
The researchers believe these findings may eventually help doctors identify biological warning signs of suicide risk more accurately.
The study also highlights the growing role of emergency departments in mental health care. Many people experiencing suicidal crises do not have regular psychiatric treatment. Some may struggle to access mental health care because of financial challenges, stigma, transportation problems, or lack of available services.
For these individuals, the emergency room may become the first and only place where they receive mental health support.
Dr. Alan Swann, senior author of the study, explained that preventing suicide requires finding risk as early as possible. He noted that many first suicide attempts happen before a person ever sees a psychiatrist.
Researchers hope tools such as EEG may eventually help emergency doctors identify patients who need immediate intervention and closer follow-up care.
Another important part of the study is its contribution to reducing stigma around suicide and mental illness. Scientists involved in the research emphasized that suicide is not simply a personal weakness or character flaw. Instead, measurable biological changes in the brain may contribute to suicidal behavior.
Dr. Ynhi Thomas, another researcher on the study, said identifying biological mechanisms behind suicide could help patients feel more understood and encourage more compassionate treatment approaches.
The findings may also lead to improved clinical trials in the future. Researchers believe EEG measurements could help scientists evaluate whether treatments like lithium are successfully targeting the brain systems involved in impulsive decision-making.
Still, experts caution that lithium is not suitable for everyone. The medication requires medical supervision because it can cause side effects and interact with other health conditions. Patients taking lithium often need regular blood tests to ensure safe levels in the body.
The researchers also stressed that suicide prevention requires much more than medication alone. Emotional support, therapy, crisis intervention, social support, and access to mental health care all remain critically important.
Although the study is still an early step, scientists believe it opens exciting possibilities for future suicide prevention efforts. By combining brain monitoring technology with targeted treatment, doctors may one day be able to detect suicide risk earlier and intervene more effectively before a crisis becomes life-threatening.
The research team plans to continue exploring how brain activity, impulsivity, and treatment responses interact over time. Their ultimate goal is to develop better strategies for helping vulnerable patients safely return to everyday life after leaving emergency care.
If you care about health, please read studies that scientists find a core feature of depression and this metal in the brain strongly linked to depression.
For more health information, please see recent studies about drug for mental health that may harm the brain, and results showing this therapy more effective than ketamine in treating severe depression.
The study was published in Experimental and Clinical Psychopharmacology.
Source: Baylor College of Medicine.
